GB0427637D0 - Topical formulations for use in the treatment or prevention of skin cancers - Google Patents

Topical formulations for use in the treatment or prevention of skin cancers

Info

Publication number
GB0427637D0
GB0427637D0 GBGB0427637.4A GB0427637A GB0427637D0 GB 0427637 D0 GB0427637 D0 GB 0427637D0 GB 0427637 A GB0427637 A GB 0427637A GB 0427637 D0 GB0427637 D0 GB 0427637D0
Authority
GB
United Kingdom
Prior art keywords
prevention
treatment
topical formulations
skin cancers
cancers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0427637.4A
Other versions
GB2421183A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stegram Pharmaceuticals Ltd
Original Assignee
Stegram Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stegram Pharmaceuticals Ltd filed Critical Stegram Pharmaceuticals Ltd
Priority to GB0427637A priority Critical patent/GB2421183A/en
Publication of GB0427637D0 publication Critical patent/GB0427637D0/en
Priority to PCT/GB2005/050251 priority patent/WO2006064291A1/en
Publication of GB2421183A publication Critical patent/GB2421183A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0427637A 2004-12-17 2004-12-17 Topical formulations for use in the treatment or prevention of skin cancers Withdrawn GB2421183A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0427637A GB2421183A (en) 2004-12-17 2004-12-17 Topical formulations for use in the treatment or prevention of skin cancers
PCT/GB2005/050251 WO2006064291A1 (en) 2004-12-17 2005-12-16 Topical formulations for use in the treatment of prevention of skin cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0427637A GB2421183A (en) 2004-12-17 2004-12-17 Topical formulations for use in the treatment or prevention of skin cancers

Publications (2)

Publication Number Publication Date
GB0427637D0 true GB0427637D0 (en) 2005-01-19
GB2421183A GB2421183A (en) 2006-06-21

Family

ID=34090200

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0427637A Withdrawn GB2421183A (en) 2004-12-17 2004-12-17 Topical formulations for use in the treatment or prevention of skin cancers

Country Status (2)

Country Link
GB (1) GB2421183A (en)
WO (1) WO2006064291A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468282A3 (en) 2005-07-12 2012-09-12 DMI Biosciences, Inc. Methods and products for treatment of diseases
SG2014008171A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
SG10201705044YA (en) 2012-12-19 2017-07-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
US20160058817A1 (en) * 2014-08-26 2016-03-03 Stephen K. Richardson Treatment of precancerous lesions with Sanguinaria Canadensis Extract/Compounded Extract

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738620A1 (en) * 1987-11-13 1989-05-24 Luderschmidt Christoph USE OF ETHISTERONE FOR TOPICAL TREATMENT OF ACNE OR ANDROGENETIC ALOPECIA
EP0952833A1 (en) * 1996-05-02 1999-11-03 Azupharma GmbH Topical penile androgen application for treatment of erectile dysfunction
AU4031897A (en) * 1996-08-29 1998-03-19 Sekisui Kagaku Kogyo Kabushiki Kaisha Stanozolol-containing percutaneously absorbable preparation
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour
US6743448B2 (en) * 2000-12-11 2004-06-01 Abraham H. Kryger Topical testosterone formulations and associated methods
SE0100857D0 (en) * 2001-03-13 2001-03-13 Tomas Hagstroem Treatment of tumors
AU2004203700B2 (en) * 2003-01-02 2007-06-21 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
WO2006004795A2 (en) * 2004-06-25 2006-01-12 The Johns Hopkins University Angiogenesis inhibitors

Also Published As

Publication number Publication date
GB2421183A (en) 2006-06-21
WO2006064291A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
EP1727530A4 (en) Topical formulations for the treatment of skin conditions
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
EP1814909A4 (en) Use of aimp2dx2 for the diagnosis and treatment of cancer
GB0520687D0 (en) Skin treatment formulations
EP1758595A4 (en) Use of lipid conjugates in the treatment of diseases
HK1110508A1 (en) Compositions and methods of their use for improving the condition and appearance of skin
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL180078A (en) 9-cis-retinal derivative for use in the treatment of 11-cis -retinal deficiency
PL2465493T3 (en) Topical compositions for the prevention and treatment of irritation of mucous cells
HK1105886A1 (en) Pharmaceutical compositions comprising l-733060 for use in the treatment of cancer tumours l-733060
EP2063859A4 (en) Cosmetic composition for the treatment of skin and methods thereof
IL178827A0 (en) Use of reboxetine for the treatment of pain
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
IL187405A0 (en) Methods and compositions for the treatment of pain
ZA200705881B (en) Formulations and treatments for well-being
PL1933840T3 (en) Use of delmopinol in the treatment of acne
ZA200709542B (en) Combination therapy in the treatment of cancer
GB2411834B (en) Composition for use in the treatment of dry skin conditions
GB0427637D0 (en) Topical formulations for use in the treatment or prevention of skin cancers
EP1797430A4 (en) Methods and compositions for the diagnosis and treatment of cancer
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
GB0701549D0 (en) Skin treatment
IL175774A0 (en) Use of siramesine in the treatment of cancer
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)